Surprisingly, the drug effects of DA were even validated in TGF‐β1‐activated LX2 (human hepatic stellate cells, a key player in liver fibrosis[24]), which seems to provide hints that the anti‐fibrotic activity of DA may be universal across multiple fibrotic diseases (Figure S2D, Supporting Information). This evidence concerns the gene TGFB1 and Hepatic fibrosis.